Bérangère Baiet

Title: Bérangère Baiet: Innovator in Glycosylation Technology

Introduction

Bérangère Baiet is a notable inventor based in Rouen, France. He has made significant contributions to the field of biotechnology, particularly in the area of glycosylation processes. His work has implications for the production of glycosylated polypeptides, which are essential in various biopharmaceutical applications.

Latest Patents

Bérangère Baiet holds a patent that involves a transformed organism containing a nucleic acid sequence operatively linked to a promoter. This sequence encodes an N-acetylglucosaminyltransferase I and/or an α-Mannosidase II. Notably, at least one β-N-acetylglucosaminidase of the transformed organism has been inactivated. The patent describes a method for producing a glycosylated polypeptide, which includes culturing the transformed organism and purifying the expressed and glycosylated polypeptide.

Career Highlights

Throughout his career, Bérangère Baiet has worked with esteemed institutions such as the University of Rouen and the French Research Institute for Exploitation of the Sea (Ifremer). His research has focused on advancing the understanding and application of glycosylation in biotechnology.

Collaborations

Bérangère Baiet has collaborated with notable colleagues, including Muriel Bardor and Romain Louvet. These partnerships have contributed to the advancement of his research and innovations in the field.

Conclusion

Bérangère Baiet is a prominent figure in the biotechnology sector, with a focus on glycosylation technology. His patent and collaborations reflect his commitment to advancing scientific knowledge and practical applications in this important area.